Percutaneous Transvalvular Micro-axial Flow Pump in Infarct Related Cardiogenic Shock - report from ACC2024

Professor Robert Roswell shared his insights on the DanGer Shock trial. Implantation of the Impella CP micro-axial flow pump in the hours after a heart attack significantly increased the rate of survival at six months among people suffering cardiogenic shock, according to a study presented at the American College of Cardiology's Annual Scientific Session. Video: https://medicaldigest.org/scientific-contents/interview:percutaneous-transvalvular-micro-axial-flow-pump-infarct-related-cardiogenic-shock